Cell Therapy News Volume 24.01 | Jan 16 2023

    0
    101








    2023-01-16 | CTN 24.01


    Cell Therapy News by STEMCELL Technologies
    Vol. 24.01 – 16 January, 2023
    TOP STORY

    Autologous T Cell Therapy for MAGE-A4+ Solid Cancers in HLA-A*02+ Patients: A Phase I Trial

    Scientists conducted a multicenter, dose-escalation, phase I trial in patients with relapsed/refractory metastatic solid tumors expressing MAGE-A4, including synovial sarcoma, ovarian cancer, and head and neck cancer.
    [Nature Medicine]

    Full ArticlePress Release
    ON1058PSC-ISSCR-Innovation-Showcase-Webinars-Set-2_final-728-x-90-B
    PUBLICATIONSRanked by the impact factor of the journal

    Implantation underneath the Abdominal Anterior Rectus Sheath Enables Effective and Functional Engraftment of Stem-Cell-Derived Islets

    Researchers demonstrated successful implantation of human pluripotent stem cell-derived islets in a new transplantation site in the abdomen, the subanterior rectus sheath, in eight nonhuman primates.
    [Nature Metabolism]

    Full Article

    Chimeric Antigen Receptor T Cells as Adjuvant Therapy for Unresectable Adenocarcinoma

    Scientists investigated whether CAR T cells could be used as an adjuvant therapy to clear residual cancer cells. They tested the feasibility of this approach in two partial resection xenograft models using mesothelin-specific CAR T cells.
    [Science Advances]

    Full ArticlePress Release

    Modulation of the Gut Microbiota Engages Antigen Cross-Presentation to Enhance Antitumor Effects of CAR T Cell Immunotherapy

    The authors investigated how vancomycin-induced gut microbiota dysbiosis affects CAR T immunotherapy using multiple preclinical models as well as clinical correlates.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Engineering C-Met-CAR NK-92 Cells as a Promising Therapeutic Candidate for Lung Adenocarcinoma

    Investigators evaluated mesenchymal-epithelial transition factor (c-Met) expression and its prognostic role in lung adenocarcinoma, and then employed the previous sequence of c-Met-Fab to design a novel c-Met-CAR and construct c-Met-CAR-natural killer cells.
    [Pharmacological Research]

    Full ArticleGraphical Abstract

    Lineage Tracking to Reveal the Fate of Hematopoietic Stem Cells Influenced by Flk2− Multipotent Progenitors after Transplantation

    The authors demonstrated that multipotent progenitors promoted T cell production of hematopoietic stem cells when both cell types were cotransplanted in mice.
    [Experimental & Molecular Medicine]

    Full Article

    Epithelial Plasticity Enhances Regeneration of Committed Taste Receptor Cells Following Nerve Injury

    Investigators revealed that injury caused by glossopharyngeal nerve transection triggered the remaining differentiated K8-positive taste receptor cells to dedifferentiate and acquire transient progenitor cell-like states during regeneration.
    [Experimental & Molecular Medicine]

    Full Article

    Generation of Anti-GD2 CAR Macrophages from Human Pluripotent Stem Cells for Cancer Immunotherapies

    Scientists used CRISPR-Cas9 gene editing methods to integrate an anti-GD2 CAR into the AAVS1 locus of human pluripotent stem cells.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Non-Clinical Cell Therapy Development Using the NCG Mouse Model as a Test System

    Researchers characterized the NCG mouse model for toxicity, engraftment, and tumorigenicity assessments of cell therapies, using CD34+ human hematopoietic stem cell adult mobilized cells with two myeloablation regimens.
    [International Journal of Toxicology]

    Abstract
    STEMCELL has implemented an Environmental Management System that is now ISO 14001-certified.
    REVIEWS

    Chemically Engineering Cells for Precision Medicine

    The authors present a comprehensive summary of the currently available chemically engineered tools, introduce their application in advanced diagnosis and precision therapy, and discuss the current challenges and future opportunities.
    [Chemical Society Reviews]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Stanford Medicine Teams Awarded $18 Million to Improve Kidney Transplant and Gene-Editing Techniques

    Physician-scientists at Stanford Medicine have received about $18 million from the California Institute for Regenerative Medicine for two projects to advance cutting-edge treatments for children: a clinical trial to improve kidney transplants, and a study of a gene-editing treatment for a rare disease.
    [Stanford Medicine]

    Press Release
    FEATURED EVENT

    4th Growth Factors in Regeneration and Regenerative Medicine Conference

    February 9 – 12, 2023
    Cancun, Mexico

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scholar Position – Cancer Drug Resistance

    University of California Los Angeles – Los Angeles, California, United States

    Research Scientist – Pancreas Tissue Engineering

    Aspect Biosystems – Vancouver, British Columbia, Canada

    Postdoctoral Fellowship – Systems Biology

    The University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Position – Tissue Regeneration Engineering

    Dankook University – Seoul, South Korea

    Associate Research Scientist – Stem Cells and Tissue Engineering

    Columbia University – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter